Hematologic Oncology Update
A podcast by Research To Practice
561 Episodio
-
Acute Leukemias Update 1 2020 | Interview with Eunice Wang, MD
Pubblicato: 26/02/2020 -
Consensus or Controversy? Clinical Investigator Perspectives on the Current and Future Management of Chronic Lymphocytic Leukemia
Pubblicato: 15/11/2019 -
CLL Update 2 2019 | Interview with Professor Dr Stephan Stilgenbauer
Pubblicato: 25/09/2019 -
CLL Update 2 2019 | Interview with Jennifer Woyach, MD
Pubblicato: 25/09/2019 -
Multiple Myeloma Update 1 2019 | Interview with S Vincent Rajkumar, MD
Pubblicato: 05/09/2019 -
Multiple Myeloma Update 1 2019 | Interview with Paul G Richardson, MD
Pubblicato: 05/09/2019 -
Multiple Myeloma Update 1 2019 | Interview with Nina Shah, MD
Pubblicato: 05/09/2019 -
Multiple Myeloma Update 1 2019 | Interview with Irene M Ghobrial, MD
Pubblicato: 05/09/2019 -
CLL Update 1 2019 | Interview with William G Wierda, MD, PhD
Pubblicato: 29/07/2019 -
CLL Update 1 2019 | Interview with Anthony R Mato, MD, MSCE
Pubblicato: 29/07/2019 -
ASCO Hem 2019 Interviews | Interview with Sonali M Smith, MD
Pubblicato: 29/07/2019 -
ASCO Hem 2019 Interviews | Interview with Noopur Raje, MD
Pubblicato: 29/07/2019 -
Oncology Today with Dr Neil Love: MPN 2019
Pubblicato: 24/07/2019 -
Anemia 2019 | Interview with Rami Komrokji, MD
Pubblicato: 16/07/2019 -
Anemia 2019 | Interview with Maria-Domenica Cappellini, MD
Pubblicato: 16/07/2019 -
Oncology Today with Dr Neil Love: WM 2019
Pubblicato: 26/06/2019 -
Myeloproliferative Neoplasms Update 1 2019 | Interview with Ruben A Mesa, MD
Pubblicato: 15/04/2019 -
Myeloproliferative Neoplasms Update 1 2019 | Interview with Aaron T Gerds, MD, MS
Pubblicato: 15/04/2019 -
Acute Leukemias Update 1 2019 | Interview with Mark Levis, MD, PhD
Pubblicato: 15/04/2019 -
Acute Leukemias Update 1 2019 | Interview with Farhad Ravandi, MD
Pubblicato: 15/04/2019
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
